These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 16284533)

  • 21. Human immunodeficiency virus treatment-induced adipose tissue pathology and lipoatrophy: prevalence and metabolic consequences.
    Hammond E; McKinnon E; Nolan D
    Clin Infect Dis; 2010 Sep; 51(5):591-9. PubMed ID: 20645860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial toxicity in the era of HAART: evaluating venous lactate and peripheral blood mitochondrial DNA in HIV-infected patients taking antiretroviral therapy.
    Montaner JS; Côté HC; Harris M; Hogg RS; Yip B; Chan JW; Harrigan PR; O'Shaughnessy MV
    J Acquir Immune Defic Syndr; 2003 Sep; 34 Suppl 1():S85-90. PubMed ID: 14562863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxicities associated with dual nucleoside reverse-transcriptase inhibitor regimens in HIV-infected children.
    Van Dyke RB; Wang L; Williams PL;
    J Infect Dis; 2008 Dec; 198(11):1599-608. PubMed ID: 19000014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum L-lactate and pyruvate in HIV-infected patients with and without presumed NRTI-related adverse events compared to healthy volunteers.
    ter Hofstede HJ; Willems HL; Koopmans PP
    J Clin Virol; 2004 Jan; 29(1):44-50. PubMed ID: 14675869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy.
    Shikuma CM; Hu N; Milne C; Yost F; Waslien C; Shimizu S; Shiramizu B
    AIDS; 2001 Sep; 15(14):1801-9. PubMed ID: 11579242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uridine abrogates the adverse effects of antiretroviral pyrimidine analogues on adipose cell functions.
    Walker UA; Auclair M; Lebrecht D; Kornprobst M; Capeau J; Caron M
    Antivir Ther; 2006; 11(1):25-34. PubMed ID: 16518957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy.
    Nolan D; Hammond E; Martin A; Taylor L; Herrmann S; McKinnon E; Metcalf C; Latham B; Mallal S
    AIDS; 2003 Jun; 17(9):1329-38. PubMed ID: 12799554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of nuclear-encoded mitochondrial LON protease in HAART-treated HIV-positive patients with lipodystrophy: implications for the pathogenesis of the disease.
    Pinti M; Gibellini L; Guaraldi G; Orlando G; Gant TW; Morselli E; Nasi M; Salomoni P; Mussini C; Cossarizza A
    AIDS; 2010 Mar; 24(6):841-50. PubMed ID: 20168207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 6-month interruption of antiretroviral therapy improves adipose tissue function in HIV-infected patients: the ANRS EP29 Lipostop Study.
    Kim MJ; Leclercq P; Lanoy E; Cervera P; Antuna-Puente B; Maachi M; Dorofeev E; Slama L; Valantin MA; Costagliola D; Lombes A; Bastard JP; Capeau J
    Antivir Ther; 2007; 12(8):1273-83. PubMed ID: 18240867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of anaemia in HIV-infected children at the University of Abuja Teaching Hospital, Gwagwalada.
    Okechukwu AA; Gambo D; Okechukwu IO
    Niger J Med; 2010; 19(1):50-7. PubMed ID: 20232757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitors.
    Sirivichayakul S; Ruxrungtham K; Ungsedhapand C; Techasathit W; Ubolyam S; Chuenyam T; Emery S; Cooper D; Lange J; Phanuphak P
    AIDS; 2003 Sep; 17(13):1889-96. PubMed ID: 12960821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term subcutaneous tissue changes among antiretroviral-naive persons initiating stavudine, zidovudine, or abacavir with lamivudine.
    Shlay JC; Sharma S; Peng G; Gibert CL; Grunfeld C
    J Acquir Immune Defic Syndr; 2008 May; 48(1):53-62. PubMed ID: 18491421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study.
    Martin A; Smith DE; Carr A; Ringland C; Amin J; Emery S; Hoy J; Workman C; Doong N; Freund J; Cooper DA;
    AIDS; 2004 Apr; 18(7):1029-36. PubMed ID: 15096806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in the peripheral blood mtDNA levels in naive patients treated by different nucleoside reverse transcriptase inhibitor combinations and their association with subsequent lipodystrophy.
    Chêne G; Amellal B; Pédrono G; Gourlain K; Rancinan C; Journot V; Cotte L; Palmer P; Castro ND; Calvez V; Molina JM;
    AIDS Res Hum Retroviruses; 2007 Jan; 23(1):54-61. PubMed ID: 17263633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significant levels of intracellular stavudine triphosphate are found in HIV-infected zidovudine-treated patients.
    Becher F; Pruvost AG; Schlemmer DD; Créminon CA; Goujard CM; Delfraissy JF; Benech HC; Grassi JJ
    AIDS; 2003 Mar; 17(4):555-61. PubMed ID: 12598776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy.
    Vigouroux C; Maachi M; Nguyên TH; Coussieu C; Gharakhanian S; Funahashi T; Matsuzawa Y; Shimomura I; Rozenbaum W; Capeau J; Bastard JP
    AIDS; 2003 Jul; 17(10):1503-11. PubMed ID: 12824788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of Severe Anemia and Changes in Hemoglobin in a Cohort of HIV-Infected Ugandan Adults Receiving Zidovudine-, Stavudine-, and Tenofovir-Containing Antiretroviral Regimens.
    Parkes-Ratanshi R; Katende D; Levin J; Wakeham K; Heiner G; Kamali A; Lalloo DG
    J Int Assoc Provid AIDS Care; 2015; 14(5):455-62. PubMed ID: 25425638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymidine analog and multinucleoside resistance mutations are associated with decreased phenotypic susceptibility to stavudine in HIV type 1 isolated from zidovudine-naive patients experiencing viremia on stavudine-containing regimens.
    Ross L; Scarsella A; Raffanti S; Henry K; Becker S; Fisher R; Liao Q; Hirani A; Graham N; St Clair M; Hernandez J;
    AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1107-15. PubMed ID: 11522180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in mitochondrial DNA copy number in blood cells from HIV-infected patients undergoing antiretroviral therapy.
    de Mendoza C; de Ronde A; Smolders K; Blanco F; Garcia-Benayas T; de Baar M; Fernández-Casas P; González-Lahoz J; Soriano V
    AIDS Res Hum Retroviruses; 2004 Mar; 20(3):271-3. PubMed ID: 15117449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection.
    Mallal SA; John M; Moore CB; James IR; McKinnon EJ
    AIDS; 2000 Jul; 14(10):1309-16. PubMed ID: 10930144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.